Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>. <i>Microorganisms</i> 2022, <i>10</i>, 560

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) targets 23 common serotypes and is recommended for use in adults in various countries to protect against pneumococcal infection. Test-negative design (TND) studies aim to include cases and controls from the same healthcare facilities; howeve...

Cijeli opis

Bibliografski detalji

Glavni autori:	Nicole Cossrow, Rennie Joshi, Kenneth Klinker, Ulrike K. Buchwald
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2022-10-01
Serija:	Microorganisms
Teme:	pneumococcal conjugate vaccines pneumococcal disease pneumococcal serotypes community-acquired pneumonia test-negative design
Online pristup:	https://www.mdpi.com/2076-2607/10/10/1987
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!